Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Cadherin 8 ELISA Kit (AC2437)
Cat.#: ASET-1026
Specifications
Description Human Cadherin 8 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Cadherin 8 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.025 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1-16 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2470 Human MAS1L ELISA Kit (AC3881) Quantitative inquiry ASET-2128 Human Chromogranin A ELISA Kit (AC3539) Quantitative inquiry ASET-1446 Human Semaphorin 7a ELISA Kit (AC2857) Quantitative inquiry ASET-2513 Human AMPK alpha 1 ELISA Kit (AC3924) Quantitative inquiry ASET-2013 Mouse Neurturin ELISA Kit (AC3424) Quantitative inquiry ASET-1127 Rat TRPV1 ELISA Kit (AC2538) Quantitative inquiry ASET-2243 Human Dopamine Receptor D1 ELISA Kit (AC3654) Quantitative inquiry ASET-2103 Human S1PR2 ELISA Kit (AC3514) Quantitative inquiry ASET-2196 Human VMAT2 ELISA Kit (AC3607) Quantitative inquiry ASET-2036 Mouse ERK1 + ERK2 ELISA Kit (AC3447) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket